- Home
- BIVI vs TXMD Comparison
BIVI vs TXMD Comparison
Compare BIVI & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- TXMD
- Stock Information
- Founded
- BIVI 2013
- TXMD 2008
- Country
- BIVI United States
- TXMD United States
- Employees
- BIVI N/A
- TXMD N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- BIVI Health Care
- TXMD Health Care
- Exchange
- BIVI Nasdaq
- TXMD Nasdaq
- Market Cap
- BIVI 14.2M
- TXMD 12.3M
- IPO Year
- BIVI N/A
- TXMD N/A
- Fundamental
- Price
- BIVI $1.91
- TXMD $1.25
- Analyst Decision
- BIVI
- TXMD
- Analyst Count
- BIVI 0
- TXMD 0
- Target Price
- BIVI N/A
- TXMD N/A
- AVG Volume (30 Days)
- BIVI 184.5K
- TXMD 447.4K
- Earning Date
- BIVI 11-12-2025
- TXMD 11-11-2025
- Dividend Yield
- BIVI N/A
- TXMD N/A
- EPS Growth
- BIVI N/A
- TXMD N/A
- EPS
- BIVI N/A
- TXMD N/A
- Revenue
- BIVI N/A
- TXMD $2,559,000.00
- Revenue This Year
- BIVI N/A
- TXMD $427.09
- Revenue Next Year
- BIVI N/A
- TXMD N/A
- P/E Ratio
- BIVI N/A
- TXMD N/A
- Revenue Growth
- BIVI N/A
- TXMD 156.93
- 52 Week Low
- BIVI $1.42
- TXMD $0.70
- 52 Week High
- BIVI $75.00
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- BIVI 46.41
- TXMD 75.50
- Support Level
- BIVI $1.81
- TXMD $0.99
- Resistance Level
- BIVI $2.07
- TXMD $1.09
- Average True Range (ATR)
- BIVI 0.13
- TXMD 0.08
- MACD
- BIVI 0.03
- TXMD 0.01
- Stochastic Oscillator
- BIVI 37.99
- TXMD 36.62
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.